DOI QR코드

DOI QR Code

Visceral Obesity Is Associated with Gallbladder Polyps

  • Lee, Jun Kyu (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Hahn, Suk Jae (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Kang, Hyoun Woo (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Jung, Jae Gu (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Choi, Han Seok (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Lee, Jin Ho (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Han, In Woong (Department of Surgery, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Jung, Jin-Hee (Department of Radiology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine) ;
  • Kwon, Jae Hyun (Department of Radiology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine)
  • Received : 2014.12.19
  • Accepted : 2015.03.22
  • Published : 2016.01.15

Abstract

Background/Aims: Gallbladder polyps (GBP) are a common clinical finding and may possess malignant potential. We conducted this study to determine whether visceral obesity is a risk factor for GBP. Methods: We retrospectively reviewed records of subjects who received both ultrasonography and computed tomography with measurements of the areas of visceral adipose tissue and total adipose tissue (TAT) on the same day as health checkups. Results: Ninety-three of 1,615 subjects (5.8%) had GBP and were compared with 186 age- and sex-matched controls. VAT (odds ratio [OR], 2.941; 95% confidence interval [CI], 1.325 to 6.529; p=0.008 for the highest quartile vs the lowest quartile) and TAT (OR, 3.568; 95% CI, 1.625 to 7.833; p=0.002 for the highest quartile vs the lowest quartile) were independent risk factors together with hypertension (OR, 2.512; 95% CI, 1.381 to 4.569; p=0.003), diabetes mellitus (OR, 2.942; 95% CI, 1.061 to 8.158; p=0.038), hepatitis B virus positivity (OR, 3.548; 95% CI, 1.295 to 9.716; p=0.014), and a higher level of total cholesterol (OR, 2.232; 95% CI, 1.043 to 4.778; p=0.039 for <200 mg/dL vs ${\geq}240mg/dL$). Body mass index and waist circumference were not meaningful variables. Conclusions: Visceral obesity measured by VAT and TAT was associated with GBP irrespective of body mass index or waist circumference.

Keywords

References

  1. Lee KF, Wong J, Li JC, Lai PB. Polypoid lesions of the gallbladder. Am J Surg 2004;188:186-190. https://doi.org/10.1016/j.amjsurg.2003.11.043
  2. Hayashi Y, Liu JH, Moriguchi H, et al. Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993. J Clin Gastroenterol 1996;23: 158-159. https://doi.org/10.1097/00004836-199609000-00021
  3. Lin WR, Lin DY, Tai DI, et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J Gastroenterol Hepatol 2008; 23:965-969. https://doi.org/10.1111/j.1440-1746.2007.05071.x
  4. Pandey M, Khatri AK, Sood BP, Shukla RC, Shukla VK. Cholecystosonographic evaluation of the prevalence of gallbladder diseases: a university hospital experience. Clin Imaging 1996;20:269-272. https://doi.org/10.1016/0899-7071(95)00034-8
  5. Yang HL, Sun YG, Wang Z. Polypoid lesions of the gallbladder: diagnosis and indications for surgery. Br J Surg 1992;79:227-229. https://doi.org/10.1002/bjs.1800790312
  6. Wan YL. Polypoid lesions of the gallbladder. Zhonghua Wai Ke Za Zhi 1989;27:450-453.
  7. Segawa K, Arisawa T, Niwa Y, et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am J Gastroenterol 1992;87:630-633.
  8. Lim SH, Kim DH, Park MJ, et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver 2007;1:138-144. https://doi.org/10.5009/gnl.2007.1.2.138
  9. Kim SY, Lee HS, Lee YS, et al. Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces. Korean J Gastroenterol 2006;48:344-350.
  10. Shim SG, Lee KT, Lee JK, et al. Prevalence and risk factors of gallbladder polyps in health screening subjects. Korean J Med 1999;57:1014-1020.
  11. Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am J Gastroenterol 1997;92:2066-2068.
  12. Jorgensen T, Jensen KH. Polyps in the gallbladder: a prevalence study. Scand J Gastroenterol 1990;25:281-286.
  13. Canturk Z, Senturk O, Canturk NZ, Anik YA. Prevalence and risk factors for gall bladder polyps. East Afr Med J 2007;84:336-341.
  14. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983;7:437-445.
  15. Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care 2002;5:481-487. https://doi.org/10.1097/00075197-200209000-00005
  16. Park YS, Kwon HT, Hwang SS, et al. Impact of visceral adiposity measured by abdominal computed tomography on pulmonary function. J Korean Med Sci 2011;26:771-777. https://doi.org/10.3346/jkms.2011.26.6.771
  17. World Health Organization, Regional Office for the Western Pacific; International Diabetes Institute; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia, 2000:19-20.
  18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
  19. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002;94:500-511. https://doi.org/10.1002/cncr.10197
  20. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 2007;96:1457-1461. https://doi.org/10.1038/sj.bjc.6603703
  21. John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 2006;23:1511-1523. https://doi.org/10.1111/j.1365-2036.2006.02915.x
  22. Kornprat P, Rehak P, Ruschoff J, Langner C. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma: a systematic analysis including primary and corresponding metastatic tumours. J Clin Pathol 2006;59:202-206. https://doi.org/10.1136/jcp.2005.028480
  23. Lai SW, Lai HC, Liu CS, Liao KF, Lin T, Lin CC. The prevalence of gallbladder polyps is higher in HBsAg positive population. Acta Gastroenterol Belg 2010;73:294-295.
  24. Yang HL, Kong L, Hou LL, et al. Analysis of risk factors for polypoid lesions of gallbladder among health examinees. World J Gastroenterol 2012;18:3015-3019. https://doi.org/10.3748/wjg.v18.i23.3015

Cited by

  1. Involvement of the hepatobiliary system and pancreas in obesity vol.89, pp.1, 2016, https://doi.org/10.17116/terarkh2017891128-133
  2. Metabolic status and lifestyle factors associated with gallbladder polyps: a covariance structure analysis vol.18, pp.None, 2016, https://doi.org/10.1186/s12876-018-0882-z
  3. Strategy for discriminating cholesterol and premalignancy in polypoid lesions of the gallbladder: a single‐centre, retrospective cohort study vol.89, pp.4, 2019, https://doi.org/10.1111/ans.14961
  4. Association between the non-HDL-cholesterol-to-HDL-cholesterol ratio and the risk of gallbladder polyp formation among men: a retrospective cohort study vol.19, pp.1, 2016, https://doi.org/10.1186/s12944-020-01322-7
  5. Gallbladder polyps: modern approaches to diagnostics and treatment vol.93, pp.1, 2016, https://doi.org/10.26442/00403660.2021.01.200544